Whooping cough vaccine aims to boost babies' protection

Baby lying in cot

The development of a world-first nasal spray vaccine could be a turning point in protection against whooping cough, helping stop the spread of the respiratory infection to vulnerable babies.

The global SUPER Study will investigate if a nasal spray vaccine called BPZE1 can prevent the bacteria that causes whooping cough, Bordetella pertussis, from causing an infection in the first instance and thereby reducing transmission in the community.

Sydney Children’s Hospital, Randwick (SCH) and The Children’s Hospital at Westmead (CHW) are two sites involved in the... read more.

You are viewing this article on the Sydney Children's Hospitals Network website. To see read the full article, please see the Kids Research website.

Read full article